The monitoring of inflammation by specific cellular markers

P Venge1

  • 1Department of Clinical Chemistry, University Hospital, Uppsala.

Insights

New assays measuring unique inflammatory cell markers offer more sensitive detection of disease activity than traditional methods. Human neutrophil lipocalin (HNL) shows promise in differentiating bacterial and viral infections.

Area of Science:

  • Clinical immunology
  • Biomarker discovery
  • Inflammatory disease diagnostics

Background:

  • Current inflammatory disease evaluation relies on conventional methods with limited sensitivity.
  • Established markers include eosinophil cationic protein (ECP) for asthma and neutrophil markers (myeloperoxidase, elastase) for infections and extracorporeal circulation.
  • There is a need for more sensitive and specific biomarkers for inflammatory conditions.

Purpose of the Study:

  • To explore the potential of unique secretory components from inflammatory cells as novel biomarkers.
  • To evaluate the diagnostic and pathophysiological utility of these cellular markers.
  • To highlight advancements in inflammatory disease monitoring through novel assays.

Main Methods:

  • Measurement of specific secretory proteins from inflammatory cells, including eosinophil cationic protein (ECP).
  • Analysis of neutrophil markers such as myeloperoxidase, elastase, and human neutrophil lipocalin (HNL).
  • Serum level assessment of these markers for clinical evaluation.

Main Results:

  • Specific cellular markers demonstrate higher sensitivity in detecting inflammatory activity compared to conventional methods.
  • ECP is extensively used for evaluating lung inflammation in asthmatics.
  • Human neutrophil lipocalin (HNL) shows superior performance in distinguishing between acute bacterial and viral infections.

Conclusions:

  • Unique cellular markers provide valuable pathophysiological insights beyond mere detection of inflammatory activity.
  • Novel assays for inflammatory cell components represent a significant advancement in diagnosing and monitoring inflammatory diseases.
  • The development of a panel of unique cellular markers holds promise for future clinical applications in personalized medicine.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Acute Inflammation I: Inflammatory Response01:26

Acute Inflammation I: Inflammatory Response

Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...
Acute Inflammation II: Cellular Phase01:26

Acute Inflammation II: Cellular Phase

The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...